product

Description
High Flow Nasal Cannula is a heated and humidified system that allows prescribed fraction of inspired oxygen (FIO2) levels to be delivered at very high flow rates.
HFNC is a promising novel oxygen delivery device, whose mechanisms of action offer some beneficial effects over conventional oxygen systems. It is considered to have a number of physiological effects: it improves oxygenation, dynamic lung compliance, homogeneity and end expiratory lung volume; it decreases anatomical dead space and generates a positive airway pressure that can reduce respiratory rate, the work of breathing, and enhance patient comfort.
 

Application
HFNC has been used as a prophylactic tool or as a treatment device mostly in patients with acute hypoxemic respiratory failure such as pre-oxygenation before intubation, immunocompromised patients and acute heart failure.
In physiological terms, HFNO improves the fraction of inspired oxygen, washes and reduces dead space, generates positive end-expiratory pressure (PEEP) and provides more comfort than cold and dry oxygen.

Advantage
During the pandemic, micomme provided over 7000 units of devices globally.
At present, micomme occupies over 50% market share in high flow filed in China.
Effectively reduce the dead space with 60L/min high flow
Unique one-way airway design, no need for disinfection, reducing equipment turnover time and the workload of medical staff.
Intelligent water-controlling system, automatically refills and maintains the optimal water level in the water chamber.
Specifications